Search for a command to run...
Asston Pharmaceuticals Ltd. shows no growth metrics and lacks profitability indicators like ROE, ROA, and EBITDA margins, positioning it as a laggard in the sector. In contrast, peers such as Sun Pharmaceutical and Dr. Reddy's Laboratories demonstrate strong growth, profitability, and efficient capital utilization, while others like Divi's Laboratories struggle with declining revenues.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Asston Pharmaceuticals Ltd. | ₹97.84 | ₹83.28Cr | 19.26 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |